Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients-Reference-Cited by-同舟云学术

Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients

Published:2014-12-11 Issue:1 Volume:169 Page:44-56
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Carmon Lior¹,Avivi Irit²³,Kovjazin Riva¹,Zuckerman Tsila²³,Dray Lillian⁴,Gatt Moshe E.⁴,Or Reuven⁴,Shapira Michael Y.⁴

Affiliation:

1. Vaxil BioTherapeutics Ltd.; Nes-Ziona Israel

2. Department of Haematology; Rambam Medical Campus; Haifa Israel

3. Technion; Israel Institute of Technology; Haifa Israel

4. Department of Bone Marrow Transplantation & Cancer Immunotherapy; Hadassah Medical Centre; Jerusalem Israel

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13245/fullpdf

Reference39 articles.

1. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2;Agrawal;Nature Medicine,1998

2. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8 + T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER;Aladin;Cancer Immunology, Immunotherapy,2007

3. Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma;Atanackovic;Leukemia,2014

4. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma;Attal;New England Journal of Medicine,2012

5. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma: follow-up analysis of the IFM 2005-02 trial;Attal;Blood (ASH Annual Meeting Abstracts),2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and challenges in anti-cancer vaccines for multiple myeloma;Frontiers in Immunology;2024-08-01

2. Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy;Journal of Cancer;2024

3. Finding Expression of MUC1 and MUC4 in the Respiratory System of the Iraqi Common Quail (Coturnix coturnix);2023-09-02

4. Therapeutic strategies to enhance immune response induced by multiple myeloma cells;Frontiers in Immunology;2023-05-18

5. Computational Design for Identification of Human Anti-MUC1 Heteroclitic Peptides in the Treatment of HER2-Positive Breast Cancer through Neural Network Training and Monomeric based Design;Current Cancer Drug Targets;2023-03